Immune Mediated Hemolytic Anemia

    Related Articles


    Immune-Mediated Hemolytic Anemia (IMHA, IMA) is a hematologic disease characterized by destruction of normal red blood cells (RBC) or destruction of RBC (hemolysis) with antigens on its surface.

    Disease Distrubution

    IMA can occur in any age animal, but young adults are most commonly affected. Females are affected more often than males, especially in Cocker Spaniels. IMA may occur alone or with other immune disorders. When both RBC and platelets are destroyed, the disease is called Evans syndrome.


    Primary & Secondary Extravascular Hemolysis

    There are several types of IMA. The most common type of hemolytic anemia is the extravascular removal of RBC that have antibodies on their surface. The antibody-coated RBCs are removed by the mononuclear phagocytic system in the spleen, bone marrow and liver. The antibody on the RBC may be directed against normal components of the RBC in which the anemia is called primary, or the antibody may be directed against a non-RBC antigen “stuck” on the cell surface.

    This form of hemolytic anemia is called secondary. Most often, the antigen on the RBC surface cannot be identified. Animals with extravascular hemolysis DO NOT have hemoglobinemia or hemoglobinuria, but jaundice and elevated levels of bilirubin in the urine (bilirubinuria) can be present depending upon the rate of hemolysis and ability of the liver to handle the bilirubin generated from degraded RBC. Some of these patients will have intravascular agglutination of RBC.

    Intravascular hemolysis

    Intravascular hemolysis occurs when complement-fixing antibodies on RBC cause RBC destruction and release of free hemoglobin into the blood. The released hemoglobin is bound to a carrier protein, haptoglobin. When all the haptoglobin is bound to hemoglobin, any free (unbound) hemoglobin will cross the glomerulus and cause hemoglobinuria in the urine), indicating hemolysis of erythrocytes within the vascular system.

    Hemoglobinemia and hemoglobinuria are observed in patients with intravascular hemolysis. These patients are at high risk for development of disseminated intravascular coagulation, thrombosis and renal failure from cell products released from destroyed RBCs.

    There are two rare conditions in which antibodies against RBC are only active at reduced temperatures. One type results in anemia and skin lesions only in cold weather as the RBC agglutinate in the extremities and impair blood flow. The other form is characterized by anemia and hemoglobinuria in cold weather.

    Signs & Symptoms

    Common signs of immune-mediated hemolytic anemia include pale mucous membranes, weakness or depression. Fever is variable. Jaundice can be present in patients with either intravascular or extravascular hemolysis.

    Enlargement of the liver or spleen are variably present as IMA can be secondary to other diseases (infections, tumors, drug reactions) or may be a part of systemic lupus erythematosus (SLE). A complete evaluation of the patient is indicated, while a full history may yield clues as to triggering factors.


    The evaluation might include complete blood count (CBC), urine tests, biochemical screen, radiographs, and ultrasound tests. If multiple organs appear to be affected, a test is indicated to evaluate for SLE.

    Treatment Options

    Treatment involves removal of the cause if known, supportive care and the administration of immune-suppressive drugs. Supportive care should include fluid therapy if the animal is not eating and drinking. Blood transfusions may be necessary if the animal is showing signs of hypoxia at rest.

    Corticosteroids, usually prednisone or prednisolone, are most commonly used in the treatment of hemolytic anemia. Corticosteroids suppress destruction of RBC and may have an effect on antibody production. If the patient responds favorably, the dose of prednisone is gradually tapered when the volume of packed red blood cells (PCV) stabilizes.

    The entire course of therapy often lasts for several months. Failure to respond to prednisone or unacceptable side effects of prednisone may necessitate the use of other immune-suppressive drugs such as cyclophosphamide, azathioprine or cyclosporine.

    Video Credits: MercolaHealthyPets
    Image Credits: Clinican’s Brief


    1. Diane Morgan – Good Dogkeeping
    2. Raghavan et al. – Diet-Related Risk Factors for Gastric Dilatation-Volvulus in Dogs of High-Risk Breeds
    3. Namikawa et al. – Gingival Overgrowth In A Dog That Received Long-term Cyclosporine For Immune-mediated Hemolytic Anemia


    Other Topics

    French Spaniel (Épagneul Français)

    History The French Spaniel, or Epagneul Français, is a medium-sized, elegant and muscled dog. An ancient breed, it...

    Herding Dogs

    Overview Herding dogs conduct livestock from one place to another by causing fear-flocking and flight behavior. They are...

    Preparing a Breeding Pair

    Female Dog Before you decide to breed your female, give careful consideration to the effort and expense, which...

    Plants in Marine Aquariums

    Overview Plants comprise a major part of a freshwater aquarium but are not really necessary in a marine...

    Berger Picard (Picardy Sheepdog)

    History & Overview The Picardy Sheepdog has very ancient origins and it is believed that the breed originated...